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iscussion
r David R. Jones (Charlottesville, Va). I have no conflict of
nterest. I would like to congratulate Dr Boffa and his coauthors on
nicely presented study. Although the GTS-STS database was r
The Journal of Thoracicstablished in 1999, its subsequent acceptance into the general
horacic surgical community has occurred at a surprisingly slow
ace. In fact, as noted by the authors, data included in this study
ikely represent less than 5% to 7% of all pulmonary resections
erformed in the United States. Therefore, this inaugural report
rom Dr Boffa and his colleagues on data harvested from the
atabase is a welcome contribution to the literature. I say this
ecause, finally, board-certified general thoracic surgeons are
racking and now presenting their results, which is in stark contrast
o other databases such as CCACS, the National Hospital Dis-
harge Survey, and others, which include outcomes from non–
oard-certified thoracic surgeons.
Dr Boffa has highlighted the contemporary operation type,
orbidity, and mortality associated with surgical treatment of
rimary lung cancer in the United States today. These results
emonstrate that our morbidities, and specifically our mortality
ates, for resection of primary lung cancer are almost half of those
eported by studies using other databases. These splendid results
ere achieved with a median length of stay of only 5 days and
neumonectomy rates of 6.5%, both far lower than what had
reviously been reported.
I have three questions for the authors. Inasmuch as one of the
rimary charges given the thoracic surgeon is to assure accurate
taging of their patient’s disease before the operation, I was sur-
rised to see that the incidence of preresection mediastinoscopy in
our series was only 21%. Do you have any idea why this number
s so low, and is it possible that it is artificially low owing to the
nherent limitations of such a study as this? Did some patients have
mediastinoscopy at a separate setting perhaps, which may not
ave been captured as a true preresection mediastinoscopy?
Second, inasmuch as several groups have shown that hospital
ase volume may affect overall survival after resection of lung
ancer, how do you think that your results fit into that literature as
e know it today?
Finally, one of the biggest criticisms of any data retrieved from
he GTS-STS database is that there is no mechanism to audit this
elf-reporting data. You mention this in the limitations of your
tudy. What effect do you think this has on your study and what is
eing done to correct this potential bias for those in the audience
ho may wish to join the database?
Dr Boffa. Thank you, Dr Jones. We were a bit surprised by the
ow mediastinoscopy rate. As you suggested, this could be a
henomenon of the database not capturing mediastinoscopy taking
lace before the resection. The STS database is a procedure-
riented database more than a patient-oriented database. As pro-
edures are entered into the database, patient identifiers are ex-
hanged for a unique Duke identifier. Although the mechanism is
uch that the same patient should be given the same Duke identifier
n multiple admissions, it is quite possible that we are missing
ediastinoscopies that were performed preoperatively.
One parameter that has been used to look at the accuracy of
reoperative staging is unsuspected N2 disease. In the current
tudy, 10.4% of patients were found to have N2 disease in their
nal pathology report. Approximately half of the patients with
2-positive disease had received induction therapy. Therefore, the
revalence of unsuspected N2 nodal disease was somewhere be-
ween 5% and 10% (as neoadjuvant may have been given for
easons other than N2 disease). The rate of unsuspected N2 disease
and Cardiovascular Surgery ● Volume 135, Number 2 253
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TSs similar to the rate reported from two large series of mediasti-
oscopies by Duke and Washington University in St Louis.
The clinical importance of unsuspected N2 disease is entirely
ependent on the extent of mediastinal lymph node evaluation.
ou never are surprised by a bill if you never check the mailbox.
he STS surgeons evaluated mediastinal lymph nodes in 65% of
esections, which is higher than the rate reported by the American
ollege of Surgeons Commission on Cancer (CCACS) in 2005.
As to the impact on volume, we have generated a curve repre-
enting all the lobectomies in the database distributed over the annual r
54 The Journal of Thoracic and Cardiovascular Surgery ● Febrobectomy volume of the submitting participants. We observed that
he lobectomies were pretty evenly distributed across participants that
verage between 20 and 100 lobectomies per year. Therefore, al-
hough I believe volume is almost certainly a factor, the GTS-STS
atabase represents a wide array of practice volumes.
Finally, the lack of a formal audit is definitely a concern. This
as been discussed at database meetings and the hope is to incor-
orate a formal audit much like the one that is in place in the
ardiac database. Until an audit is implemented, however, this will
emain a valid criticism.
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